Prof. Dr. med. Christian Fankhauser

Berufserfahrung

07/2024 – 02/2026
Leitender Arzt
Urologie
Luzerner Kantonsspital

2022 – 2024
Oberarzt mbF
Urologie
Luzerner Kantonsspital

2021 – 2022
Oberarzt Urologie
Luzerner Kantonsspital

2020 – 2021
Senior Fellow Uroonkologie
The Christie, NHS Trust
Manchester

2019 – 2020
Assistenzarzt Urologie
Universitätsspital Zürich

2018 – 2019
Assistenzarzt Urologie
Clara Spital Basel

2016 – 2019
Assistenzarzt Urologie
Universitätsspital Zürich

2014 – 2016
Assistenzarzt Dep. Chirurgie (common trunk)
Universitätsspital Zürich

2013
U.a. Unterassistent Chirurgie
Kantonsspital Winterthur

Bildungsweg

2023
Titularprofessur Universität Luzern

2022
Europäisch zert. Roboterchirurge: European Board of Robotic Urology

2022
Schwerpunkt Operative Urologie FMH

2020
Facharzt Urologie

2020
Habilitation Universität Zürich

2016 – 2020
Master of Public Health, Harvard School of Public Health, Boston, USA

2014
Doktorat Universität Zürich

2007 – 2013
Medizinstudium Universität Zürich

Forschung und Weiterentwicklung

• Leitung Research & Development Projekte Urologie LUKS mit >100 laufenden Forschungs- und Optimierungsprojekten
• Drittmitteleinwerbung und Verwaltung von >3.4 Mio CHF, davon >0.5 Millionen CHF laufend und transferierbar
• 125 Originalpublikationen, H-Index 29
• Assitant Editor Eur Urology (highest ranked urology journal Impact Factor 25.3)
• Betreuung/Leitung von 9 abgeschlossenen und 16 laufenden Master-/Doktorarbeiten
• Vizepräsident Urogenital Group der Schweizerischen Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK)
• Board member, European Society of Oncological Urology (ESOU)
• Vorsitzender Penile & Testis Cancer Young Academic Urologists (YAU)
• Guideline member Enhanced Recovery After Surgery (ERAS), radical cystectomy

Auszeichnungen und Preise

2023
Reviewer of the Month, European Urology

2022
Reviewer of the year, European Urology Oncology

2022
Best poster prize, EMUC 2022

2021
Research prize, 77. Annual Meeting of the Swiss Urological Association (SGU), Interlaken, CH (10’000 €)

2020
1st poster prize, British national germ cell conference, virtual meeting 03/2021 (460 €)

2019
EAU-Guideline Cup, 2nd place

2018
Best abstract, Plenary session presentation at the European Multidisciplinary Meeting on Urological Cancers 2018 (500 €)

2017
Best poster in Clinical Science, 73. Annual Meeting of the Swiss Urological Association (SGU), Lugano, CH (900 €)

2017
Quality Q-Award of the University Hospital Zürich (Project: Interdisciplinary Testis Cancer Clinic), Zürich, CH (360 €)

2012
Award of the Medical Faculty, University of Zurich for the best medical master thesis” (360 €)
Research project: “Validity and responsiveness of the Core Outcome Measures Index (COMI) for the neck”

Drittmittel / Forschungsförderung

2024
Follow-up care recommondations for testicular cancer: The Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS) / Nachsorge-Empfehlungen bei Hodenkrebs: Die Schweizisch Österreichisch Deutsche Hodenkrebs Kohortenstudie (SAG TCCS)
INFORMATORY KFS-6065-02-2024
217 760 CHF (Co-PI, peer reviewed)

2024
Oncological and Functional Follow-up after Cystectomy and Trimodal Therapy
INFORMATORY KFS-6065-02-2024
313,780 CHF (PI, peer reviewed)

2024
Oncological and Functional Follow-up after Cystectomy and Trimodal Therapy
INFORMATORY KFS-6065-02-2024

2024
SAKK Network Award
CHF 1,000,000 CHF (peer reviewed)

2024
Swiss Consensus follow-up consensus conference
CHF 86,000 CHF (pharma sponsoring and Krebsforschung Schweiz)

2023
SAKK Swiss Fellowship 2023
CHF 30,000 CHF (peer reviewed)

2022
Swiss Bridge Foundation, Optimierungsmöglichkeiten des Patientenpfades vor und nach Entfernung der Harnblase
CHF 119,560 CHF (no peer review)

2022
EAU SUO congress exchange (2’000 CHF)

2022
Implementation of microRNA-371 into the follow-up protocol of men with localised testicular germ cell tumours (microRNA-TARGET)
KFS-5489-02-2022
Krebsliga (369,750 CHF, peer reviewed)

2020
Preoperative smoking cessation program in cancer patients undergoing surgery: a randomised controlled trial
HSR-5217-11-2020
Krebsliga (249’313 CHF, peer reviewed)

2020
Improving outcomes for men with germ-cell cancer through a supra-regional second-opinion online portal and national expert advice
Krebsliga (178’000 CHF, Co-PI, peer reviewed)

2019
Huggenberger Krebsstiftung und Fonds für akademischen Nachwuchs
Project Master of Public Health, Harvard School of Public Health (10’000 CHF)

2019
SAKK/Dr. Paul Janssen Fellowship
Project Master of Public Health, Harvard School of Public Health (30’000 CHF)

2019
Fonds zur Förderung des akademischen Nachwuchses (FAN) and selection as Ernst Göhner Fellow
Project Master of Public Health, Harvard School of Public Health (25’000 CHF)

2019
Short Visits Travel Grant funded European Urological Scholarship Programme (EUSP)
2000 CHF
Project, Short Visit in Manchester, UK to prepare a surgical urooncology fellowship

2018
Research Grant funded by the Marlis Geiser-Lemken Stiftung
Research Project “Validation of automated Gleason Scoring” (10’000 CHF)

2018
Research Prize awarded by the “Walter und Gertrud Siegenthaler Stiftung”
Research project: “miRNA signatures to personalize care of patients with metastatic germ cell cancer”, (50’000 CHF)

2018
Research Bursary of the “Stiftung für urologische Forschung” (20’000 CHF)
Course: “Program in Clinical Effectiveness” at the Harvard School of Public Health

2017
Research Grant of the Swiss Cancer League, Co-Applicant KFS-3999-08-2016
miRNA in testis cancer (362’000 CHF)

2016
Research Bursary of the University Hospital Zurich (16’000 CHF competitive)
Course: “Program in Clinical Effectiveness” at the Harvard School of Public Health

2015
Research Bursary “Forschungsförderungspreis (FFP)” of medAlumni, University of Zurich
(10’000 CHF competitive)

2013
Travel Grant of the Swiss study foundation (3’000 CHF)
Course: “Practical Statistics in Medical Research – UCL London, UK)